Cleared Special

K133396 - VDRIVE WITH V-SONO

K133396 is an FDA 510(k) clearance for VDRIVE WITH V-SONO, manufactured by Stereotaxis, Inc.. The device is a Class 2 Cardiovascular device with product code DQX cleared through the Special 510(k) pathway after a 92-day FDA review.

Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Feb 2014
Decision
92d
Days
Class 2
Risk

K133396 is an FDA 510(k) clearance for the VDRIVE WITH V-SONO. Classified as Wire, Guide, Catheter (product code DQX), Class II - Special Controls.

Submitted by Stereotaxis, Inc. (St. Louis, US). The FDA issued a Cleared decision on February 6, 2014 after a review of 92 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1330 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Standard predicate reliance. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

FDA 510(k) Submission Details - K133396

510(k) Number K133396 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 06, 2013
Decision Date February 06, 2014
Days to Decision 92 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
33d faster than avg
Panel avg: 125d · This submission: 92d
Pathway characteristics
Modification to existing cleared device.

DQX Device Classification - Class 2, Special Controls

Product Code DQX Wire, Guide, Catheter
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1330
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQX Wire, Guide, Catheter

All 768
Devices cleared under the same product code (DQX) and FDA review panel - the closest regulatory comparables to K133396.
HYDROPHILIC COATED GUIDEWIRE
K133155 · Lake Region Medical · Apr 2014
MANDREL GUIDEWIRE
K140485 · Lake Region Medical · Mar 2014
ASAHI GAIA FIRST, SECOND, THIRD
K133865 · Asahi Intecc Co., Ltd. · Mar 2014
MEDTRONIC CONFIDA BRECKER CURVE GUIDEWIRE
K132623 · Medtronic · Dec 2013
INQWIRE DIAGNOSTIC GUIDE WIRE
K133230 · Merit Medical Systems, Inc. · Dec 2013
MEDIVALVE ACWIRE
K132545 · Medivalve , Ltd. · Nov 2013